An examination of America’s legacy of vilifying some substances and deifying others. In an exhaustive series of well-referenced examples, the author updates the concept, discussing recent developments such as congressional hearings on tobacco and the troubling state of the antidepressant industry. He explores how the reputation of a drug, as well as its effects, are often heavily dependent on contextual factors distinct from its pharmacological action.

Full text of review…